What you're calling "peer review" is what I would call "discussed" or "debated" which it certainly was.
I dispute your claim that the new paradigm is superior.
Accepted. But now there is Arxiv and Biorxiv and even Medrxiv—so we're back to where things were, it seems.
reply
What you're calling "peer review" is what I would call "discussed" or "debated" which it certainly was.
I dispute your claim that the new paradigm is superior.